Kangpu Biopharmaceuticals Received CDE Approval for Phase IIb Clinical Trial of KPG-818 in Moderate to Severe Cutaneous Manifestations of SLE HEFEI, China, April 28, 2025 /PRNewswire/ — Kangpu Biopharmaceuticals, Ltd. announced today… CISION PRNewswireApril 28, 2025
Appknox Launches Storeknox, Revolutionizes Mobile App Security with Continuous Store Monitoring New solution empowers enterprises to protect against post-launch app threats, fake apps… CISION PRNewswireApril 28, 2025
Celltrion to present six abstracts in inflammatory bowel disease (IBD) at 2025 Digestive Disease Week® (DDW) Six abstracts accepted for presentation includes post hoc analyses and real-world evidence… CISION PRNewswireApril 28, 2025
Press ReleaseSmall Lab Co., Ltd., obtains FDA OTC approval. Leading the K-Beauty wave SEOUL, South Korea, April 28, 2025 /PRNewswire/ — SmallLab Inc, a microneedle platform… CISION PRNewswireApril 28, 2025
Press ReleaseSky Labs' CART BP pro at the Heart of New Research on Sleep Apnea and Nocturnal Hypertension SEOUL, South Korea, April 28, 2025 /PRNewswire/ — Sky Labs, a health-tech startup… CISION PRNewswireApril 28, 2025
TDH Holdings, Inc. Reports Full Year 2024 Audited Financial Results BEIJING, April 28, 2025 /PRNewswire/ — TDH Holdings, Inc. (NASDAQ: PETZ) ("TDH"… CISION PRNewswireApril 28, 2025
Press ReleaseCensys Launches Threat Hunting Solution to Proactively Track and Defend Against Targeted Adversaries This solution helps security teams hunt faster, accelerate investigations and eliminate threats… CISION PRNewswireApril 28, 2025
WOORI FINANCIAL GROUP INC. FILES ITS ANNUAL REPORT ON FORM 20-F SEOUL, South Korea, April 28, 2025 /PRNewswire/ — On April 28, 2025,… CISION PRNewswireApril 28, 2025
